M Findlay
15 works · 2,141 citations · h-index 7
Top works
- Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
- Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study
- Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.
- 34 Phase II study of LY231514 in patients with advanced non-small cell lung cancer (NSCLC)
- Measurement of plasma 5-fluorouracil by high-performance liquid chromatography with comparison of results to tissue drug levels observed using in vivo 19F magnetic resonance spectroscopy in patients on a protracted venous infusion with or without interferon-α
- Novel germlineCDH1mutations in hereditary diffuse gastric cancer families
- Survival benefit with Xeloda (capecitabine)/docetaxel vs docetaxel: analysis of post-study therapy.
- PCN4: ECONOMIC CONSEQUENCES OF DIFFERENCES IN THE ADVERSE-EVENTS (AE) PROFILE OF CAPECITABINE vs. MAYO CLINIC (M) -REGIMEN IN PREVIOUSLY UNTREATED ADVANCED/ METASTATIC COLORECTAL CANCER.
- A randomized phase II study comparing capecitabine (C) with C plus oral cyclophosphamide (CCy) in patients (pts) with advanced breast cancer (BC)
- Monitoring tumour response to 5-fluorouracil in colorectal cancer liver metastases using positron emission tomography and F-18 deoxyglucose
- Melanoma control: few answers, many questions.
- CN3: COST-SAVINGS FOR CAPECITABINE DUE TO ORAL ADMINISTRATION IN PREVIOUSLY UNTREATED ADVANCED/ METASTATIC COLORECTAL CANCER
- O ral C apecitabine C ompared W ith I ntravenous Fluorouracil P lus L eucovorin i n P atients W ith M etastatic Colorectal C ancer: R esults o f a L arge P hase I II S tudy
- GROUP STUDY